Details
Stereochemistry | RACEMIC |
Molecular Formula | C11H17N2O2S.Na |
Molecular Weight | 264.32 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].CCCC(C)C1(CC)C(=O)NC(=S)[N-]C1=O
InChI
InChIKey=AWLILQARPMWUHA-UHFFFAOYSA-M
InChI=1S/C11H18N2O2S.Na/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15;/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16);/q;+1/p-1
Molecular Formula | C11H18N2O2S |
Molecular Weight | 242.338 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Molecular Formula | Na |
Molecular Weight | 22.9898 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Sodium thiopental (also known as Sodium Pentothal, thiopental) was discovered in 1930s by investigators working for Abbott Laboratories. Thiopental sodium was used for the induction of general anesthesia and is used as an adjunct to provide hypnosis during balanced anesthesia with other anesthetic agents, including analgesics and muscle relaxants. Thiopental sodium was also used as an adjunct for control of convulsive disorders of various etiology, including those caused by local anesthetics. Finally, thiopental sodium had been used to reduce the intracranial pressure in patients with increased intracranial pressure, if controlled ventilation is provided. Nevertheless, these prescriptions of drug were discontinued. In addition, this drug was banned for use in US executions. Thiopental sodium acts through the CNS with particular activity in the mesencephalic reticular activating system. It was shown, that mechanism of action of sodium thiopental via GABAA receptor. Thiopental binds at a distinct binding site associated with a Cl- ionopore at the GABAA receptor, increasing the duration of time for which the Cl- ionopore is open. The post-synaptic inhibitory effect of GABA in the thalamus is, therefore, prolonged.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2093872 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18619475 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Palliative | PENTOTHAL Approved UsePentothal (Thiopental Sodium for Injection) is indicated (1) as the sole anesthetic agent for brief (15 minute) procedures, (2) for induction of anesthesia prior to administration of other anesthetic agents, (3) to supplement regional anesthesia, (4) to provide hypnosis during balanced anesthesia with other agents for analgesia or muscle relaxation, (5) for the control of convulsive states during or following inhalation anesthesia, local anesthesia, or other causes, (6) in neurosurgical patients with increased intracranial pressure, if adequate ventilation is provided, and (7) for narcoanalysis and narcosynthesis in psychiatric disorders. |
Doses
Dose | Population | Adverse events |
---|---|---|
500 mg multiple, intravenous (starting) Dose: 500 mg Route: intravenous Route: multiple Dose: 500 mg Sources: |
unhealthy, 31 years (range: 19 -44 years) n = 13 Health Status: unhealthy Age Group: 31 years (range: 19 -44 years) Sex: M+F Population Size: 13 Sources: |
Other AEs: Hypothermia... |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Hypothermia | 1 patient | 500 mg multiple, intravenous (starting) Dose: 500 mg Route: intravenous Route: multiple Dose: 500 mg Sources: |
unhealthy, 31 years (range: 19 -44 years) n = 13 Health Status: unhealthy Age Group: 31 years (range: 19 -44 years) Sex: M+F Population Size: 13 Sources: |
PubMed
Title | Date | PubMed |
---|---|---|
Thrombophlebitis following thiopentone injection. | 1972 Nov |
|
Thiopentone anaphylaxis--case report. | 1975 Aug |
|
Venous complications after intravenous injection of diazepam, flunitrazepam, thiopentone and etomidate. | 1980 Jun |
|
Ketamine hypertension and the renin-angiotensin system. | 1983 |
|
Another case of grand mal seizure after fentanyl administration. | 1984 Apr |
|
Fatal haemopathological consequences of general anaesthesia. | 1989 Jan |
|
Complications and side effects during thiopentone therapy in patients with severe head injuries. | 1992 May |
|
Protective effect of thiopental against cerebral ischemia during circulatory arrest. | 1999 Aug |
|
Effect of some psychotropic drugs and a barbiturate on mycoplasmas. | 2000 Apr |
|
The influence of the timing of administration of thiopentone sodium on nitric oxide-mediated neurotoxicity in vitro. | 2000 Mar 1 |
|
Retrospective analysis of drug-induced urticaria and angioedema: a survey of 2287 patients. | 2001 Nov |
|
Effect of thiopental, propofol, and etomidate on vincristine toxicity in PC12 cells. | 2002 |
|
Torsade de pointes and sudden death induced by thiopental and isoflurane anesthesia in dogs with cardiac electrical remodeling. | 2002 Jan |
|
Seventy-four defibrillations for sotalol-induced torsades de pointes. | 2004 Jul-Aug |
|
Comparative benefit of preemptively applied thiopental for propofol injection pain: the advantage over lidocaine. | 2004 Mar |
|
Intravenous propofol precipitates the hypotension induced by inadvertent epidural thiopental injection. | 2006 Dec |
|
Synergism of isothermal regimen and sodium succinate in experimental therapy of barbiturate coma. | 2006 Jul |
|
Fulminant hyperammonaemia induced by thiopental coma in rats. | 2006 Jul 25 |
|
Thiopental protects human T lymphocytes from apoptosis in vitro via the expression of heat shock protein 70. | 2008 Apr |
|
Theophylline-associated status epilepticus in an infant: pharmacokinetics and the risk of suppository use. | 2009 Nov |
|
The effect of a 3 : 1 volume mixture of propofol 1% and thiopental 2.5% in reducing the pain on injection of propofol in children. | 2010 Jun |
|
[Use of midazolam for refractory status epilepticus in children]. | 2010 Jun-Jul |
|
Pretreatment with dexmedetomidine or thiopental decreases myoclonus after etomidate: a randomized, double-blind controlled trial. | 2010 Mar |
|
Incidence of postoperative delirium is high even in a population without known risk factors. | 2014 Apr |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.medicines.org.uk/emc/medicine/14338
Thiopental Sodium 500 mg Injection is administered intravenously normally as a 2.5% w/v (500 mg in 20 ml) solution. On occasions it may be administered as a 5% w/v solution (500 mg in 10 ml).
The intravenous injection preparation should be used after reconstitution of the sterile powder with Water for Injections, usually to produce a 2.5% w/v solution and this should be discarded after seven hours.
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18619475
In cultured spinal cord slices from mice, thiopental reduced action potential activity with an EC50 of 16.6 ± 2.4 μM. Recordings of GABAA and glycine receptor-mediated inhibitory currents indicated that the effect was largely mediated by GABAA receptors and that glycine receptors were not relevant targets. Specifically, 20 μM thiopental prolonged the decay time of spontaneous GABAergic inhibitory postsynaptic currents (sIPSCs) more than twofold. Although this prolongation of decay time increased the inhibitory charge per sIPSC the concomitant strong reduction of sIPSC frequency resulted in less inhibitory current entering the neurons via this route. However, 20 μM thiopental also induced a tonic current of 30 ± 10 pA, mediated by GABAA receptors; 50 μM thiopental nearly abolished sIPSC activity but augmented tonic currents to 69 ± 14 pA.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:04:43 GMT 2023
by
admin
on
Fri Dec 15 16:04:43 GMT 2023
|
Record UNII |
49Y44QZL70
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C67084
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
||
|
NCI_THESAURUS |
C245
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
||
|
CFR |
21 CFR 522.2444
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
||
|
DEA NO. |
2100
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
||
|
CFR |
21 CFR 522.2444A
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
||
|
CFR |
21 CFR 522.2444B
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
102166
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | |||
|
THIOPENTAL SODIUM
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | Description: A yellowish white powder; odour, characteristic. Solubility: Freely soluble in water and ethanol (~750 g/l) TS; practically insoluble in ether R. Category: General anaesthetic. Storage: Thiopental sodium should be kept in a tightly closed container, protected from light. Additional information: Thiopental sodium is hygroscopic. Even in the absence of light, it is gradually degraded on exposure to a humid atmosphere, the decomposition being faster at higher temperatures. Requirements: Thiopental sodium contains not less than 97.0% and not more than the equivalent of 102.0% of C11H17N2NaO2S, calculated with reference to the dried substance. | ||
|
71-73-8
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | |||
|
DTXSID1021744
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | |||
|
200-763-1
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | |||
|
m10773
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | Merck Index | ||
|
12832575
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | |||
|
433
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | |||
|
SUB10981MIG
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | |||
|
282416
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | RxNorm | ||
|
DBSALT001409
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | |||
|
100000091816
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | |||
|
SUB04816MIG
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | |||
|
CHEMBL441
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | |||
|
Sodium thiopental
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | |||
|
9561
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | |||
|
759557
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | |||
|
49Y44QZL70
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | |||
|
C66599
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |